UBS Group’s Healthcare Services Group HCSG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.07M | Buy |
124,992
+12,091
| +11% | +$255K | ﹤0.01% | 4675 |
|
|
2026
Q1 | $2.09M | Sell |
112,901
-97,588
| -46% | -$1.93M | ﹤0.01% | 4930 |
|
|
2025
Q4 | $4.02M | Buy |
210,489
+84,545
| +67% | +$1.52M | ﹤0.01% | 4246 |
|
|
2025
Q3 | $2.12M | Sell |
125,944
-38,614
| -23% | -$575K | ﹤0.01% | 4887 |
|
|
2025
Q2 | $2.47M | Buy |
164,558
+13,397
| +9% | +$178K | ﹤0.01% | 4592 |
|
|
2025
Q1 | $1.52M | Buy |
151,161
+34,781
| +30% | +$381K | ﹤0.01% | 4920 |
|
|
2024
Q4 | $1.35M | Buy |
116,380
+41,563
| +56% | +$474K | ﹤0.01% | 5078 |
|
|
2024
Q3 | $836K | Sell |
74,817
-29,264
| -28% | -$321K | ﹤0.01% | 4811 |
|
|
2024
Q2 | $1.1M | Sell |
104,081
-8,890
| -8% | -$98.6K | ﹤0.01% | 4335 |
|
|
2024
Q1 | $1.41M | Sell |
112,971
-15,663
| -12% | -$174K | ﹤0.01% | 4290 |
|
|
2023
Q4 | $1.33M | Buy |
128,634
+1,955
| +2% | +$19.5K | ﹤0.01% | 4235 |
|
|
2023
Q3 | $1.32M | Buy |
126,679
+23,841
| +23% | +$297K | ﹤0.01% | 3845 |
|
|
2023
Q2 | $1.54M | Sell |
102,838
-138,613
| -57% | -$2.01M | ﹤0.01% | 3805 |
|
|
2023
Q1 | $3.35M | Buy |
241,451
+215,332
| +824% | +$2.84M | ﹤0.01% | 2901 |
|
|
2022
Q4 | $313K | Sell |
26,119
-61,314
| -70% | -$810K | ﹤0.01% | 5079 |
|
|
2022
Q3 | $1.06M | Buy |
87,433
+52,568
| +151% | +$775K | ﹤0.01% | 3711 |
|
|
2022
Q2 | $607K | Sell |
34,865
-282,502
| -89% | -$4.87M | ﹤0.01% | 4111 |
|
|
2022
Q1 | $5.89M | Buy |
317,367
+33,591
| +12% | +$580K | ﹤0.01% | 2381 |
|
|
2021
Q4 | $5.05M | Buy |
283,776
+173,666
| +158% | +$3.38M | ﹤0.01% | 2806 |
|
|
2021
Q3 | $2.75M | Sell |
110,110
-21,368
| -16% | -$578K | ﹤0.01% | 3285 |
|
|
2021
Q2 | $4.15M | Sell |
131,478
-149,377
| -53% | -$4.54M | ﹤0.01% | 2889 |
|
|
2021
Q1 | $7.87M | Buy |
280,855
+1,666
| +0.6% | +$50.3K | ﹤0.01% | 2168 |
|
|
2020
Q4 | $7.84M | Buy |
279,189
+94,001
| +51% | +$2.27M | ﹤0.01% | 2041 |
|
|
2020
Q3 | $3.99M | Buy |
185,188
+70,631
| +62% | +$1.65M | ﹤0.01% | 2407 |
|
|
2020
Q2 | $2.8M | Sell |
114,557
-162,877
| -59% | -$3.86M | ﹤0.01% | 2565 |
|
|
2020
Q1 | $6.63M | Sell |
277,434
-151,593
| -35% | -$3.9M | ﹤0.01% | 1694 |
|
|
2019
Q4 | $10.4M | Buy |
429,027
+84,623
| +25% | +$2.1M | ﹤0.01% | 1919 |
|
|
2019
Q3 | $8.37M | Sell |
344,404
-838,131
| -71% | -$21.2M | ﹤0.01% | 1916 |
|
|
2019
Q2 | $35.9M | Sell |
1,182,535
-78,169
| -6% | -$2.58M | 0.01% | 853 |
|
|
2019
Q1 | $41.6M | Sell |
1,260,704
-337,632
| -21% | -$12.9M | 0.02% | 730 |
|
|
2018
Q4 | $64.2M | Buy |
1,598,336
+28,663
| +2% | +$1.21M | 0.03% | 487 |
|
|
2018
Q3 | $63.8M | Buy |
1,569,673
+237,689
| +18% | +$9.87M | 0.03% | 565 |
|
|
2018
Q2 | $57.5M | Buy |
1,331,984
+169,919
| +15% | +$6.75M | 0.02% | 588 |
|
|
2018
Q1 | $50.5M | Buy |
1,162,065
+233,246
| +25% | +$11.4M | 0.02% | 634 |
|
|
2017
Q4 | $49M | Buy |
928,819
+13,257
| +1% | +$695K | 0.02% | 682 |
|
|
2017
Q3 | $49.4M | Sell |
915,562
-43,000
| -4% | -$2.21M | 0.02% | 598 |
|
|
2017
Q2 | $44.9M | Sell |
958,562
-48,439
| -5% | -$2.24M | 0.02% | 608 |
|
|
2017
Q1 | $43.4M | Buy |
1,007,001
+60,881
| +6% | +$2.5M | 0.02% | 603 |
|
|
2016
Q4 | $37.1M | Buy |
946,120
+13,279
| +1% | +$507K | 0.02% | 677 |
|
|
2016
Q3 | $36.9M | Buy |
932,841
+638,682
| +217% | +$25M | 0.02% | 642 |
|
|
2016
Q2 | $12.2M | Sell |
294,159
-22,714
| -7% | -$872K | 0.01% | 1244 |
|
|
2016
Q1 | $11.7M | Buy |
316,873
+16,167
| +5% | +$562K | 0.01% | 1225 |
|
|
2015
Q4 | $10.5M | Buy |
300,706
+23,326
| +8% | +$848K | 0.01% | 1376 |
|
|
2015
Q3 | $9.35M | Buy |
277,380
+94,504
| +52% | +$3.19M | 0.01% | 1431 |
|
|
2015
Q2 | $6.04M | Buy |
182,876
+1,318
| +0.7% | +$41.5K | ﹤0.01% | 1885 |
|
|
2015
Q1 | $5.83M | Sell |
181,558
-8,033
| -4% | -$260K | ﹤0.01% | 1939 |
|
|
2014
Q4 | $5.86M | Buy |
+189,591
| New | +$5.62M | ﹤0.01% | 1971 |
|
Other funds holding HCSG
RA
UBS Group's HCSG Position: Q2 2026 in Review
UBS Group increased its Healthcare Services Group (HCSG) stake by 11% in Q2 2026, buying an estimated $255K and bringing the position to 124,992 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4675.
UBS Group first reported a position in HCSG in Q4 2014 and has held it in 47 quarters since. The position peaked at $64.2M in Q4 2018. 274 funds tracked by Wall St. Rank hold HCSG as of Q2 2026.
- UBS Group held 124,992 shares of Healthcare Services Group worth $3.07M as of Q2 2026.
- UBS Group bought 12,091 Healthcare Services Group shares in Q2 2026, an estimated $255K.
- Healthcare Services Group made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4675 holding.
- UBS Group first reported a position in Healthcare Services Group in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Healthcare Services Group position peaked at $64.2M in Q4 2018.
- 274 funds tracked by Wall St. Rank held Healthcare Services Group as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.